DANIELLE LEFEBVRE: Open Payments
NPI 1114523727 · AUBURN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 25 payments from 10 companies in 2025. Trend: 2023 $255 · 2024 $426 · 2025 $482
Food & beverage: $482
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $107 |
| PFIZER INC. | 4 | $66 |
| Biogen, Inc. | 4 | $62 |
| Astellas Pharma US Inc | 2 | $61 |
| SHIELD THERAPEUTICS INC | 4 | $61 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $43 |
| MILLICENT US INC | 1 | $33 |
| Dexcom, Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $14 |
Products named: ABRYSVO, Mirena, ZURZUVAE, Veozah, ACCRUFER, Lynkuet, INTRAROSA, Dexcom G6 Transmitter.
Industry payments across NY — which companies pay providers there.
